Inflammatory Marker Predicts Outcome of Oral Squamous Cell Carcinoma Receiving Chemo-Radiotherapy

Wei Sun,1 Meng Gao,2 Guangyuan Hu,1 Xun Yuan1 1Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430020, Hubei, People’s Republic of China; 2Department of Medical Ultrasound, Tongji Hospital of Tongji Medical College, Hu...

Full description

Bibliographic Details
Main Authors: Sun W, Gao M, Hu G, Yuan X
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:Cancer Management and Research
Subjects:
ldh
Online Access:https://www.dovepress.com/inflammatory-marker-predicts-outcome-of-oral-squamous-cell-carcinoma-r-peer-reviewed-article-CMAR
Description
Summary:Wei Sun,1 Meng Gao,2 Guangyuan Hu,1 Xun Yuan1 1Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430020, Hubei, People’s Republic of China; 2Department of Medical Ultrasound, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430020, Hubei, People’s Republic of ChinaCorrespondence: Xun YuanDepartment of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, Hubei, People’s Republic of ChinaTel +86-027-8366-3406Fax +86-027-8366-3630Email yuanxun@tjh.tjmu.edu.cnBackground: Inflammation is involved in the progression of oral squamous cell carcinoma. We therefore postulate that a blood-based inflammatory marker, the neutrophil-to-lymphocyte ratio, could help to predict the prognosis in patients with oral squamous cell carcinoma receiving chemo-radiotherapy, and build a prognostic nomogram.Methods: In 111 cases of oral squamous cell carcinoma, several baseline variables, including inflammatory markers and lactate dehydrogenase, were measured within the week of chemo-radiotherapy initiation as predictors of mortality and separate risk scores were developed.Results: Dichotomized neutrophil-to-lymphocyte ratio was found to be associated with AJCC stage (p< 0.001). Patients with oral squamous cell carcinoma with a low neutrophil-to-lymphocyte ratio survived longer than those with a high neutrophil-to-lymphocyte ratio (overall survival HR=2.39, 95% CI 1.24– 4.61, p=0.009). The Harrell’s concordance (C)-statistic of the nomogram was 0.74 and the calibration curve demonstrated the goodness of fit.Conclusion: The inflammatory marker neutrophil-to-lymphocyte ratio, obtained before chemo-radiotherapy, was an independent factor of survival prediction for oral squamous cell carcinoma. The nomogram incorporating immunological markers could more accurately predict individualized survival probability than the existing models. These findings are significant for the creation of personalized treatment strategies in the clinical setting.Keywords: nomogram, oral squamous cell carcinoma, LDH, platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio
ISSN:1179-1322